ArticleRespiratory research2025
Early development and dynamics of nasopharyngeal microbiota in infants during the COVID-19 pandemic: a 2-year prospective birth cohort study.
Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe nasopharyngeal microbiota, which plays a crucial role in respiratory health and disease during infancy, was significantly affected by the COVID-19 pandemic lockdown in children and adults. This study aimed to prospectively explore the dynamics of the nasopharyngeal microbiota in infants during the COVID-19 pandemic.
methodsWe conducted a prospective birth cohort study at Hospital Sant Joan de Déu (Barcelona, Spain) involving 32 neonates born between December 2019 and December 2020. Epidemiological, clinical and microbiological variables as well as nasopharyngeal aspirates were collected during the firsts two years of life. Nasopharyngeal aspirates were used to characterize the nasopharyngeal microbiota through 16 S rRNA gene sequencing.
resultsOur findings highlight the stabilization of the nasopharyngeal microbiota composition by 12 months of age. Key factors influencing nasopharyngeal microbiota patterns in the first two years of life included a history of upper respiratory tract infection episodes, a pattern of rapid post-natal weight gain, pneumococcal carriage detection, recent receipt of systematic vaccination, and the use of antibiotics and corticosteroids. Notably, rapid post-natal weight gain was associated with differences in the microbiota composition, with overrepresentation of potential beneficial bacteria such as Dolosigranulum pigrum and Corynebacterium spp., underrepresentation of Haemophilus influenzae and Moraxella catarrhalis, and functional pathways with enhanced metabolic activity.
conclusionsThese findings demonstrate early stabilization of the nasopharyngeal microbiota composition by 12 months of age during the COVID-19 period and highlight the interplay between nasopharyngeal microbiota dynamics and early post-natal weight gain, with potential long-term impacts on metabolic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.